Saturday August 15, 2020

Gabriel Scientific in €2.3m Middle East deal

The Irish company behind an infection-resistant range of bedding products is valuing a distribution agreement in the Middle East at US$3 million (€2.3 million).

27th July, 2013
Ayman Saleh, group chief executive, Julphur Pharmaceuticals; Sheikh Saqer Humaid Al Qasimi, Douglas Collins, Gabriel Scientific; and Rajiv Nakani, director Planet Pharmacy.

**Done Deal:** €2.3 million

**The clincher:** "This third deal will see us build our business in the growing Arab health sector. We have invested resources to establish our credentials as key innovators and to capture market share and growth." - *David Woolfson, founder*


Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 7 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago